Guilherme Caldas Emrich
Chairman at BIOMM S.A.
Net worth: 16 M $ as of 2024-04-29
Profile
Mr. Guilherme Caldas Emrich is Chairman at Centro de Inovações CSEM Brasil, Founding Partner at FIR Capital Partners - Gestão de Investimentos SA, and Chairman at BIOMM SA. He is on the Board of Directors at Oncoclínicas do Brasil Serviços Médicos SA.
He received his undergraduate degree from Universidade Federal de Minas Gerais.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BIOMM SA
3.17% | 2022-11-29 | 4,020,123 ( 3.17% ) | 16 M $ | 2024-04-29 |
Guilherme Caldas Emrich active positions
| Companies | Position | Start |
|---|---|---|
| BIOMM S.A. | Chairman | 2013-12-15 |
FIR Capital Partners - Gestão de Investimentos SA
 FIR Capital Partners - Gestão de Investimentos SA Investment ManagersFinance FIR Capital Partners - Gestão de Investimentos (FIR Capital) is the Brazil-based venture capital arm of Draper Fisher Jurvetson in the US. The firm was founded by Guilherme Emrich and Marcus Regueira in 1999 to invest in innovative start-up, emerging or growing companies with significant growth potential. Headquartered in Belo Horizonte, FIR Capital became a subsidiary of Draper Fisher Jurvetson in 2007. They pursue investments where they can add value, making direct investments and investing through funds in world-class companies with the potential for exponential growth. Their flagship fund, Fundotec I, was one of the first venture capital funds in Brazil. | Founder | 2011-07-18 |
| Fundação Dom Cabral | Director/Board Member | - |
| Government of Brazil | Corporate Officer/Principal | - |
Former positions of Guilherme Caldas Emrich
| Companies | Position | End |
|---|---|---|
Biobras SA
 Biobras SA Pharmaceuticals: MajorHealth Technology Part of Novo Nordisk A/S, Biobras SA is a Brazilian company that manufactures diabetes products. The company is based in Montes Claros, Brazil. The company was founded by Guilherme Caldas Emrich. Biobras was acquired by Novo Nordisk A/S on November 19, 2002 for $15.70 million. | Founder | 2001-12-31 |
| Fundação Biominas | Chairman | 1999-01-31 |
Oninn Centro de Inovacoes
 Oninn Centro de Inovacoes Miscellaneous Commercial ServicesCommercial Services Oninn Centro de Inovacoes provides research and development services. It develops and industrializes technologies transforming basic research into applied products in the areas of nanotechnology, microtechnology, systems engineering, telecom and information technology. The company was founded by Guilherme Caldas Emrich in 2006 and is headquartered in Belo Horizonte, Brazil. | Founder | - |
| ONCS BRAS | Director/Board Member | - |
Training of Guilherme Caldas Emrich
| Universidade Federal de Minas Gerais | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| BIOMM S.A. | Health Technology |
| ONCS BRAS | Health Services |
| Private companies | 5 |
|---|---|
FIR Capital Partners - Gestão de Investimentos SA
FIR Capital Partners - Gestão de Investimentos SA Investment ManagersFinance FIR Capital Partners - Gestão de Investimentos (FIR Capital) is the Brazil-based venture capital arm of Draper Fisher Jurvetson in the US. The firm was founded by Guilherme Emrich and Marcus Regueira in 1999 to invest in innovative start-up, emerging or growing companies with significant growth potential. Headquartered in Belo Horizonte, FIR Capital became a subsidiary of Draper Fisher Jurvetson in 2007. They pursue investments where they can add value, making direct investments and investing through funds in world-class companies with the potential for exponential growth. Their flagship fund, Fundotec I, was one of the first venture capital funds in Brazil. | Finance |
Oninn Centro de Inovacoes
Oninn Centro de Inovacoes Miscellaneous Commercial ServicesCommercial Services Oninn Centro de Inovacoes provides research and development services. It develops and industrializes technologies transforming basic research into applied products in the areas of nanotechnology, microtechnology, systems engineering, telecom and information technology. The company was founded by Guilherme Caldas Emrich in 2006 and is headquartered in Belo Horizonte, Brazil. | Commercial Services |
| Fundação Biominas | |
Biobras SA
Biobras SA Pharmaceuticals: MajorHealth Technology Part of Novo Nordisk A/S, Biobras SA is a Brazilian company that manufactures diabetes products. The company is based in Montes Claros, Brazil. The company was founded by Guilherme Caldas Emrich. Biobras was acquired by Novo Nordisk A/S on November 19, 2002 for $15.70 million. | Health Technology |
| Government of Brazil | Government |
- Stock Market
- Insiders
- Guilherme Caldas Emrich
